Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).

Johnson & Johnson プロフィール



企業コードJNJ

会社名Johnson & Johnson

上場日Oct 31, 2080

最高経営責任者「CEO」Duato (Joaquin Boix)

従業員数138100

証券種類Ordinary Share

決算期末Oct 31

本社所在地One Johnson & Johnson Plaza

都市NEW BRUNSWICK

証券取引所NASDAQ OMX NASDAQ Basic NYSE

国United States of America

郵便番号08933

電話番号17325242455

ウェブサイトhttps://www.jnj.com/

企業コードJNJ

上場日Oct 31, 2080

最高経営責任者「CEO」Duato (Joaquin Boix)

Johnson & Johnsonの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Joaquin Boix Duato

Chairman of the Board, Chief Executive Officer

307.82K

-15.75%

Ms. Jennifer L. Taubert

Executive Vice President, Worldwide Chairman, Innovative Medicine

194.45K

Ms. Kathryn E. Wengel

Executive Vice President, Chief Technical Operations & Risk Officer

114.63K

Mr. Joseph J. Wolk

Chief Financial Officer, Executive Vice President

85.01K

+0.07%

Dr. John C. Reed, M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

24.91K

+57.22%

Ms. Vanessa Broadhurst

Executive Vice President - Global Corporate Affairs

23.00K

Ms. Kristen Mulholland

Executive Vice President, Chief Human Resources Officer

19.83K

+28.80%

Ms. Elizabeth Forminard, J.D.

Executive Vice President, Chief Legal Officer

16.99K

-38.68%

Mr. Hubert Joly

Independent Director

5.00K

Ms. Marillyn A. Hewson

Lead Independent Director

3.00K

詳細を見る

会社名